Pathologic examination and staging of rectal carcinoma: A critical review

Pathologica

Volumn 102, Issue 1, 2010, Pages 12-27

  Greco, P ^a   Magro, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cancer; Pathological examination; Rectum; Review; Staging

Indexed keywords

ABDOMINAL SURGERY; CANCER STAGING; HUMAN; LYMPH NODE; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RECTUM; RECTUM TUMOR; REVIEW;

COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASM STAGING; RECTAL NEOPLASMS; RECTUM;

EID: 77952395659     PISSN: 00312983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. Maughan NJ, Morris E, Forman D, Quirke P. The validity of the Royal College of pathologists' colorectal cancer minimum dataset within a population. Br J. Cancer 2007;97:1393-1398
2. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 2003;4:695-702.
3. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix. Arch Pathol Lab Med 2000;124:1016-1025
4. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003;16:376-388.
5. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Virchows Arch 2007;450:1-13.
6. Quirke P, Morris E. Reporting colorectal cancer. Histopathology 2007;50:103-112
7. Treanor D, Quirke P. Pathology of colorectal cancer. Clinical Oncology 2007;19:769-776
8. Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Archiv Pathol Lab Med 2008;132:1182-1193
9. Washington MK. Colorectal carcinoma. Selected issues in pathologic examination and staging and determination of prognostic factors. Archiv Pathol Lab Med 2008;132:1600-1607
10. Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729-1734
11. Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTGCO16 randomised clinical trial. Lancet 2009;373:821-828
12. Leo E, Belli F, Miceli R, Mariani L, Gallino GF, Battaglia L, et al. Distal clearance margin of 1 cm or less: a safe distance in lower rectum cancer surgery. Int J Colorectal Dis 2009;24:317-322
13. Andreola S, Leo E, Belli F, Bonfanti G, Sirizzotti G, Greco P, et al. Adenocarcinoma of the lower third of the rectum surgically treated with a < 10-mm distal clearance: preliminary results in 35 NO patients. Ann Surg Oncol 2001;8:611-615
14. Glehen O, Chapet O, Adham M, Nemoz JC, Gerard JP, Lyons Oncology Group. Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 2003;90:996-998
15. Kuvshinoff B, Maghfoor I, Miedema B. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are
16. Moore HG, Riedel E, Minsky BD. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003;10:80-85
17. Rutkowski A, Bujko K, Nowacki MP, Chmielik E, NasierowskaGuttmejer A, Wojnar A. Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe? Ann Surg Oncol 2008;15:3124-3131
18. Stocchi L, Nelson H, Sargent DJ, O'Connell MJ, Tepper JE, Krook JE, et al. North Central Cancer Treatment Group, Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001;19:3895-3902
19. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996-999
20. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorect Dis 1988;3:127-131
21. Quirke P, Scott N. The pathologist's role in the assessment of local recurrence in rectal carcinoma. Surg Oncol Clin North Am 1992;1:1-17.
22. Birbeck KF, Macklin CP, Tiffin J, Parsons W, Dixon MF, Mapstone NP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235 449-457
23. Ludeman L, Shepherd NA. Macroscopic assessment and dissection of colorectal cancer resection specimens. Current Diagnostic Pathology 2006;12:220-230
24. Avallone A, Delrio P, Guida C, Tatabgelo F, Petrillo A, Marone P, et al. Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy durig preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study. B J Cancer 2006;94:1809-1815
25. Greco P, Andreola S, Magro G, Belli F, Giannone G, Gallino GF, et al. Potential pathological understaging of pT3 rectal cancer with less than 26 lymph nodes recovered: a prospective study based on a resampling of 50 rectal specimens. Virchows Arch 2006;449:647-651
26. Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology 2005;47:123-131
27. Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 1995; 48:849-855
28. Anwar MA, D'Souza F, Coulter R, Memon R, Khan IM, Memon MA. Outcome of acutely perforated colorectal cancers: experience of a single district general hospital. Surg Oncol 2006;15:91-96
29. Kim Y-M, Kim N-K, Min B-S, Lee K-Y, Sohn S-K, Cho C-H. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Am J Surg Pathol 2009;249:965-972
30. Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696
31. Greco P, Magro G. Comments on the reporting of lymph nodes and tumour budding in the checklist of colorectal carcinoma. Virchows Arch 2007;450:359-360
32. Greco P, Magro G. Staging in colorectal cancer: problems for pathologists. Histopathology 2007;51:552-580
33. Compton CC. Optimal pathologic staging: defining stage II disease. Clin Cancer Res 2007;13:6862-6870
34. Goldstein SN, Sandorf W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Path 1997;106:209-216
35. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002;26:179-189
36. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003;10:213-218
37. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157-163
38. Wong JH, Bowles BJ, Bueno R, Shimizu D. Impact on the number of negative nodes on disease-free survival in colorectal cancer. Dis Colon Rectum 2002;45:1341-1345
39. Assad SM, Jubelirer SJ, Welch CA. Prognostic indicators for stage II (Dukes' stage B) adenocarcinoma of the colon. WV Med J 2005; 101:210-213
40. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DJ. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial Int-0089. J Clin Oncol 2003;21:2912-2919
41. Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is impoved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002; 235:458-463
42. Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005;41:272-279
43. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 2005;87:219-225
44. Maurel J, Launoy G, Grosclaude P, Gignoux M, Arveux P, Mathieu-Daudé H, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel. A French population-based study. Cancer 1998;82:1482-1486
45. Morris EJA, Maughan NJ, Forman D, Quirke P. Who treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology. Gut 2007;56:1419-1425
46. Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0Mo colorectal carcinomas? J Surg Oncol 2002;81:63-69
47. Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum? Virchows Arch 2003;443:133-138
48. Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumors (UICC). 7th edition. New York: WileyLiss 2009.
49. George A, Primrose J, Talbot R, Smith J, Mullee M, Bailey D, et al. Colorectal Cancer Audit Working Group, Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologist. Br J Cancer 2006;95:841-847
50. Gorog D, Nagy P, Peter A, Perner F. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res 2003;9:180-183
51. Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg 2002;6:883-890
52. Miller EA, Woosley J, Martin CF, Sandler RS. Hospital-to hospital variation in lymph node detection after colorectal resection. Cancer 2004;101:1065-1071
53. Morris EJA, Maughan NJ, Forman D, Quirke P. Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist. J Clin Oncol 2007;25:2573-2579
54. Tekkis PP, Smith JJ, Heriot AG, Darzi AW, Thompson MR, Stamatakis JD. Association of coloproctology of Great Britain and Ireland. A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum 2006;49:1673-1683
55. Wheeler JMD, Warren BF, Mortensen NJ, Ekanyaka N, Kulacoglu H, Jones AC, et al. Quantification of histologic regression of rectal cancer after irradiation. Dis Colon Rectum 2002;45:1051-1056
56. Wijesuriya RE, Deen KI, Hewavisenthi J, Balawardana J, Perera M. Neoadjuvant therapy for rectal cancer downstages tumor but reduces lymph node harvest significantly. Surg Today 2005;3:442-445
57. Wright FC, Law CHL, Last L, Khalifa M, Arnaout A, Naseer Z, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 2003;10:903-909
58. Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee S-W, et al. Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009;74:7896-8802
59. Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, et al. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol 2008;15:3118-3123
60. Andreola S, Leo E, Belli F, Bufalino R, Tomasic G, Lavarino C, et al. Manual dissection of adenocarcinoma of the lower third rectum specimens for detection of lymph node metastases smaller than 5 mm. Cancer 1996;77:607-612
61. Herrera L, Villarreal JR. Incidence of metastases from rectal adenocarcinoma in small lymph nodes detected by a clearing technique. Dis Colon Rectum 1992;35:783-788
62. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253-1256
63. Hida J, Mori N, Kubo R, Matsuda T, Morikawa E, Kitaoka M, et al. Metastases from carcinoma of the colon and rectum detected in small lymph nodes by the clearing method. J Am Coll Surg 1994;178:223-228
64. Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannèe G, Bioulac-Sage P, et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 2008; 32:45-50.
65. Kim Y-W, Kim N-K, Min B-S, Lee K-Y, Sohn S-K, Cho C-H, et al. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 2009;100:1-7.
66. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, et al. Carcinoma of the colon and rectum. In: Hamilton S, Aaltonen L, ed. Pathology and Genetics tumors of the digestive system (W.H.O.). Lyon: IARC Press 2000, pp.105-119.
67. Chapuis PH, Dent OF, Fisher F, Newland RC, Pheils MT, Smyth E, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72:698-702.
68. Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors of operable rectal cancer. Lancet 1984; 2:733-736
69. Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM, et al. The grading of rectal cancer: histological perspectives and multivariate analysis of 447 cases. Histopathology 1986;10:437-459
70. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Kajiwara Y, Sato T, et al. Histologial grading of colorectal cancer. A simple and objective method. Am J Surg Pathol 2008;247:811-818
71. Riddell RH, Petras RE, Williams JT. Colorectal carcinoma. In: Rosai J, Sobin L,ed. Atlas of Tumor Pathology- Tumors of the intestines. Washington: AFIP 2002, pp. 133-188.
72. Chandler I, Houlston RS. Interobserver agreement in grading of colorectal cancer-findings from a nationwide web-based survey of histopathologists. Histopathology 2008; 52:494-499
73. Compton CC, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: colorectal working group. Cancer 2000;88:1739-1757
74. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997;112:1096-1102
75. Stewart CJR, Morris M, de Boer B, Iacopetta B. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology 2007;51:372-378
76. Stewart C, Hillery S, Havlat M. Serosal involvement in colorectal carcinoma. Histopathology 2006;49:435-437
77. Keshava A, Chapuis PH, Chan C, Lin BP, Bokey EL, Dent OF. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 2007;9:609-618
78. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A, for AJCC 7th Ed'n Hindgut Taskforce (HTF), TN categorization for rectal and colon cancers based on national survival outcome data. J Clin Oncol (Abstract) 2008; 26:4020.
79. Jessup JM, Compton CC, Washington MK. For the sake of clarity about pT4 category of colorectal cancer. Archiv Pathol Lab Med 2009;133:340-341
80. Cawthorn SJ, Parums DV, Gibbs NM. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-1059
81. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohnberger W, Heřmánek P. The prognostic inhomogeneity inpT3 rectal carcinomas. Int J Colorectal Dis 2001;16:298-304.
82. Steel MCA, Woods R, Mackay JM, Chen F. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 2002;72:483-487
83. Newland RC, Chapuis PH, Smyth EJ. The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 1987;60:852-857
84. Picon AI, Moore HG, Sternberg SS, Minsky BD, Paty PB, Blumberg D, et al. Prognostic significance of depth of gross or micoscopic perirectal fat invasion in T3N0M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 2003;18:487-492
85. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, et al. Role of the circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344:707-711
86. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimetre but two millimetres is the limit. Am J Surg Pathol 2002;26:350-357
87. Wibe A, Rendedal PR, Svensson T. Prognostic significance of the circumferential resection margin following total mesorectal exision for rectal cancer. Br J Surg 2002;89:327-334
88. Luna-Perez P, Bustos-Cholico E, Alvarado I, Maffuz A, Rodríguez-Ramírez S, Gutiérrez de la Barrera M, et al. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and lower anterior resection. J Surg Oncol 2005;90:20-25
89. Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival ? Int J Radiat Oncol Biol Phys 2005;63:745-752
90. Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, et al. A uniform residual tumor (R) classification. Integration of the R classification and the circumferential margin status. Cancer 2009;115:3483-3488
91. Nagtegaal ID, Marijnen CAM, Hranenbarg EK, van de Velde CJH, Krieken JHJM. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Am J Surg Pathol 2002;26:350-357
92. Bernstein TE, Endreseth BH, Romundstad P, Wibe A. Circumferential resection margin as a prognostic factor in rectal cancer. British J Surg 2009;96:1348-1357
93. Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A, et al. Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol 2003;29:862-866
94. Fisher ER, Colangelo L, Wieand S, Fisher B, Wolmark N. Lack of influence of cytokeratin-positive micrometastases in negative node patients with colorectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Projects protocols R-01 and C-01. Dis Colon Rectum 2003;46:1021-1026
95. García-Sáenz JA, Sáenz MC, González L, Pérez-Segura P, Puente J, López-Tarruella S, et al. Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma. Clin Transi Oncol 2006;676:676-680
96. Shimoyama M, Yamazaki T, Suda T, Hatakeyama K. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2. Dis Colon Rectum 2003;46:333-339
97. Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 2000;7:601-608
98. Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3 N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 2000;88:2228-2238
99. Harrison JC, Dean PJ, El-Zeky F, Zwaag RV. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer. Hum Pathol 1995;26:31-38
100. Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extrandoal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998;41:55-61.
101. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon: a critical review. Histopathology 2007;51:141-149
102. Harrison JC, Dean PJ, El-Zeky F, Zwaag RV. From Dukes trough Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994; 25:498-505
103. Puppa G, Maisonneuve P, Sonzogni A, Masullo M, Capelli P, Chilosi M, et al. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol 2007;20:843-855
104. Puppa G, Ueno H, Kayahara M, Capelli P, Canzonieri V, Colombari R, et al. Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases. Mod Pathol 2009;22:410-415
105. Ueno H, Mochizuki, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, et al. Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol 2007;127:287-294
106. Tateishi S, Arima S, Futami K, Kawahara K, Tachikawa D, Naritomi K, et al. A clinicopathological investigation of tumor nodules in colorectal cancer. Surg Today 2005;35:377-384
107. Ono C, Yoshinaga K, Enemoto M, Sugihara K. Discontinuous rectal cancer spread in the mesorecum and the optimal distal clearance margin in situ. Dis Colon Rectum 2002;45:744-749
108. Ratto C, Ricci R, Rossi C, Morelli U, Vecchio FM, Doglietto GB. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002;45:733-742
109. Ueno H, Mochizuki H. Clinical significance of extrabowel skipper cancer infiltration in rectal cancer. Surg Today 1997;27:617-622
110. Prabhudesai A, Arif S, Finlayson CJ, Kumar D. Impact of microscopic extranodal tumour deposits on the outcome of patients with rectal cancer. Dis Colon Rectum 2003;46:1531-1537
111. Wang Z, Zhou ZG, Wang C, Zhao GP, Chen YD, Gao HK, et al. Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections. World J Gastroenterol 2004;10:2949-2953
112. Wang Z, Zhou Z, Wang C, Zhao GP, Chen YD, Gao HK, et al. Microscopic spread of low rectal cancer in regions of mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis 2005;20:231-237
113. Wang C, Zhou Z, Wang Z. Patterns of neoplastic foci and lymph node micrometastasis within mesorectum. Langenbecks Arch Surg 2005;390:312-318
114. th edition. New York:Wiley-Liss 1997.
115. th edition. New York: Wiley-Liss 2002.
116. Howarth SM, Morgan JM, Williams GT. The new (6th edition) TNM classification of colorectal cancer - a stage too far. Gut (Abstract) 2004;53:A21.
117. Di Fabio F, Nascimbeni R, Villanacci V, Baronchelli C, Bianchi D, Fabbretti G, et al. Prognostic variables for cancer-related survival in node-negative colorectal carcinomas. Dig Surg 2004;21:128-133
118. Minsky B, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer 1988;61:1417-1424
119. Minsky B, Mies C, Rich T, Recht A. Lymphatic vessel invasion in an independent prognostic factor for survival in colorectal cancer. Int J Radiât Oncol Biol Phys 1989;17:311-318
120. Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I. The futureof the TNM staging system in colorectal cancer: time for a debate? Lancet Oncology 2007;8:651-657
121. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcnoma. Dis Colon Rectum 1991;34:798-804.
122. Harris EI, Levin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, et al. Lymphovascular invasion in colorectal cancer. An interobserver variability study. Am J Surg Pathol 2008;32:1816-1821
123. Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 1996;78:2313-2317
124. Courtney ED, West NJ, Kaur C, Ho J, Kalber B, Hagger R, et al. Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Disease 2009;11:150-156
125. Knudsen JB, Nilsson T, Sprechler M, Johansen A, Christensen N. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum 1983;26:613-617
126. Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 1988;208:379-389
127. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ, Morson BC. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 1981;5:141-163
128. Abdulkader N, Abdulla K, Rakha E, Kaye P. Routine elastic staining assists detection of vascular invasion in colorectal cancer. Histopathology 2006;49:487-492
129. Vass DG, Ainsworth R, Anderson JH, Murray D, Foulis AK. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol 2006;59:207-210
130. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, Kearney G, Fielding LP. Histopathology reporting in large bowel cancer. J Clin Pathol 1981;34:509-513
131. Nakamura T, Mitomi H, Kikuchi S, Ohtani Y, Sato K. Evaluation of the usefulness of tumour budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology 2005;52:1432-1435
132. Okuyama T, Nakamura T, Yamaguchi M. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum 2003;46:1400-1406
133. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007;50:151-162
134. Wang LM, Kevans D, Mulcahy H, O'Sullivan J, Fennelly D, Hyland J, et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 2009;33:134-141
135. Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-Kenudson M, Tanaka N Deanoff G, Giovannucci EL, Fuchs CS. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node coun, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009;15:6412-6420
136. Graham DM, Appelman HD. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol 1990; 3:332-335
137. Greenson JK, Huang S-C, Herron C, Moreno V, Bonner JD, Tomsho LP, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 2009;33:126-133
138. Alexander J, Watanabe T, Wu T-T, Rashid A, Li S, Hamilton SR. Histopathologic identification of colon cancer with microsatellite instability. Am J Pathol 2001;158:527-535
139. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740
140. Tveit KM, Guldvog II, Hagen S, Trondsen E, Harbitz T, Nygaard K, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer: Noerwegian adjuvant rectal cancer project group. Br J Surg 1997;84:1130-1135
141. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23.
142. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Fetiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994;73:2680-2686
143. Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-146
144. Bonnen M, Crane M, Vauthey JN, Slabber J, Delclos ME, Rodriguez-Bigas M, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiât Oncol Biol Phys 2004;60:1098-1105
145. Kim CJ, Yeatman TJ.Coppola D, Williams B, Barthel JS, Dinwoodie W, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001;234:352-358
146. Schell SR, Zlotecki RA, Mendnhall WM, Marsh RW, Vauthey JN, Copeland EM 3rd. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 2002;194:584-591